Anticorps Polyclonal de lapin anti-iNOS
iNOS Polyclonal Antibody for WB, FC (Intra), ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris et plus (2)
Applications
WB, IHC, IF, FC (Intra), CoIP, ELISA, Cell treatment
Conjugaison
Non conjugué
N° de cat : 22226-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules Caco-2, cellules RAW 264.7 |
| Résultats positifs en FC (Intra) | cellules RAW 264.7 traitées au LPS, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| WB | See 143 publications below |
| IHC | See 29 publications below |
| IF | See 77 publications below |
| CoIP | See 1 publications below |
Informations sur le produit
22226-1-AP cible iNOS dans les applications de WB, IHC, IF, FC (Intra), CoIP, ELISA, Cell treatment et montre une réactivité avec des échantillons Humain, souris
| Réactivité | Humain, souris |
| Réactivité citée | rat, Humain, poulet, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | iNOS Protéine recombinante Ag17567 |
| Nom complet | nitric oxide synthase 2, inducible |
| Masse moléculaire calculée | 1153 aa, 131 kDa |
| Poids moléculaire observé | 110-130 kDa, 65-70 kDa |
| Numéro d’acquisition GenBank | BC130283 |
| Symbole du gène | iNOS |
| Identification du gène (NCBI) | 4843 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
NOS2, also named as iNOS and NOS2A, produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. NO is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission, antimicrobial and antitumoral activities. NOS2 is a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. iNOS has a very short half-life due to rapid degradation by calpain. iNOS monomer is a direct substrate of calpain I and can be cleaved by calpain I at the canonical CaM-binding site(503-532aa) of iNOS, and then a ~70kD band can be detected by western (PMID:11786228).
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for iNOS antibody 22226-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Mol Ther Epsin1-mediated exosomal sorting of Dll4 modulates the tubular-macrophage crosstalk in diabetic nephropathy | ||
Theranostics Multifunctionally disordered TiO2 nanoneedles prevent periprosthetic infection and enhance osteointegration by killing bacteria and modulating the osteoimmune microenvironment | ||
Proc Natl Acad Sci U S A Sleep deficiency exacerbates periodontal inflammation via trigeminal TRPV1 neurons | ||
J Nanobiotechnology Injectable photocrosslinking spherical hydrogel-encapsulated targeting peptide-modified engineered exosomes for osteoarthritis therapy | ||
Cancer Lett Inducible nitric oxide synthase (iNOS)-activated Cxcr2 signaling in myeloid cells promotes TGFβ-dependent squamous cell carcinoma lung metastasis | ||
ACS Appl Mater Interfaces Extracellular Matrix-Mimicking Hydrogel with Angiogenic and Immunomodulatory Properties Accelerates Healing of Diabetic Wounds by Promoting Autophagy |


